245 related articles for article (PubMed ID: 9415611)
1. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
[TBL] [Abstract][Full Text] [Related]
2. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
3. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
[TBL] [Abstract][Full Text] [Related]
4. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
Abbott JJ; Oliveira AM; Nascimento AG
Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
7. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.
Goldblum JR; Reith JD; Weiss SW
Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatous dermatofibrosarcoma protuberans metastasized to the lung: preservation of CD34 expression in tumor cells.
Ohtani N; Fukusato T; Tezuka F
Pathol Int; 1998 Dec; 48(12):989-93. PubMed ID: 9952345
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma Protuberans: A Study of 148 Patients.
Marcoval J; Moreno-Vílchez C; Torrecilla-Vall-Llosera C; Muntaner-Virgili C; Pérez Sidelnikova D; Sanjuán X; Penín RM
Dermatology; 2024; 240(3):487-493. PubMed ID: 38228098
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
12. Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases.
Szollosi Z; Nemes Z
J Clin Pathol; 2005 Jul; 58(7):751-6. PubMed ID: 15976346
[TBL] [Abstract][Full Text] [Related]
13. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas.
Connelly JH; Evans HL
Am J Surg Pathol; 1992 Oct; 16(10):921-5. PubMed ID: 1415902
[TBL] [Abstract][Full Text] [Related]
15. Fibrosarcomatous change in dermatofibrosarcoma protuberans.
Wrotnowski U; Cooper PH; Shmookler BM
Am J Surg Pathol; 1988 Apr; 12(4):287-93. PubMed ID: 3354755
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
17. Atrophic and plaquelike dermatofibrosarcoma protuberans.
Davis DA; Sánchez RL
Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
[TBL] [Abstract][Full Text] [Related]
18. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
Minter RM; Reith JD; Hochwald SN
J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors.
Ding J; Hashimoto H; Enjoji M
Cancer; 1989 Aug; 64(3):721-9. PubMed ID: 2545326
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation.
Kuzel P; Mahmood MN; Metelitsa AI; Salopek TG
J Cutan Med Surg; 2015; 19(1):28-34. PubMed ID: 25775660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
